|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||||||
  The Journal of World Intellectual PropertyVolume 9 Issue 5, Pages 573 - 591 Published Online: 15 Aug 2006 © 2009 Blackwell Publishing Ltd
Abstract | References | Full Text: HTML, PDF (Size: 153K) | Related Articles | Citation Tracking  TRIPS-Plus Intellectual Property Rules: Impact on Thailand's Public Health Copyright © 2006 Blackwell Publishing Ltd KEYWORDS Thailand • TRIPS-plus • FTA • access to medicines ABSTRACTThailand has proved that a well-funded, politically supported public policy could be effective in preventing the spread of HIV/AIDS on a national scale. It is currently facing increased pressure to accept higher standards of intellectual property (IP) protection (the so-called Trade-Related Aspects of Intellectual Property Rights (TRIPS)-plus) under bilateral free trade agreements (FTA) proposed by the United States. The proposed US FTA threatens to restrict the measures the country can take to pursue affordable drugs, and will affect the ability of Thailand to continue its successful anti-retroviral (ARV) treatment and other healthcare programmes. This article argues that the TRIPS-plus regime generates a negative impact on poor people's access to medicines, and the ARV treatment programme in Thailand is presented as an illustrative example. | 
| |||||||||||
